Caszyme CEO Says CRISPR Gene Editing Could Help Patients, Save The Planet

Caszyme CEO and 2022 In Vivo Rising Leader Monika Paule is on a mission to expand the CRISPR toolbox of available proteins to enhance diagnostic tools, therapeutics and even agricultural practices.